101 related articles for article (PubMed ID: 26676292)
1. Clinical Efficacy of α1-Adrenargic Receptor Antagonist Naftopidil 75 mg/day in Patients with Benign Prostatic Hyperplasia.
Kadekawa K; Sugaya K; Ashitomi K; Nishijima S
Low Urin Tract Symptoms; 2010 Sep; 2(2):106-12. PubMed ID: 26676292
[TBL] [Abstract][Full Text] [Related]
2. Influence of Naftopidil on Plasma Monoamine Levels and Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.
Kadekawa K; Sugaya K; Mukoyama H; Sakumoto M; Shimabukuro H; Shimabukuro S; Matayoshi Y; Onaga T; Ashitomi K; Nishijima S
Low Urin Tract Symptoms; 2016 May; 8(2):100-5. PubMed ID: 27111621
[TBL] [Abstract][Full Text] [Related]
3. Symptoms Predictive for Efficacy of Naftopidil in Patients with Benign Prostate Hyperplasia.
Funahashi Y; Hattori R; Yoshino Y; Matsukawa Y; Sassa N; Gotoh M
Low Urin Tract Symptoms; 2011 Sep; 3(2):113-7. PubMed ID: 26676397
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Naftopidil 75 mg with Tamsulosin Hydrochloride 0.2 mg in the Treatment of Lower Urinary Tract Symptoms with Benign Prostatic Hyperplasia.
Shigemura K; Yamamichi F; Matsumoto M; Tanaka K; Yamashita M; Arakawa S; Fujisawa M
Low Urin Tract Symptoms; 2012 Sep; 4(3):136-9. PubMed ID: 26676620
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of an alpha1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia.
Takahashi S; Tajima A; Matsushima H; Kawamura T; Tominaga T; Kitamura T
Int J Urol; 2006 Jan; 13(1):15-20. PubMed ID: 16448426
[TBL] [Abstract][Full Text] [Related]
7. Early Efficacy of an α1 Adrenoceptor Antagonist, Naftopidil, against Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia.
Ishizuka O; Nishizawa O; Takeda M; Nomura T; Kagawa S
Low Urin Tract Symptoms; 2011 Sep; 3(2):79-85. PubMed ID: 26676391
[TBL] [Abstract][Full Text] [Related]
8. Correlations among Lower Urinary Tract Symptoms, Bother, and Quality of Life in Patients with Benign Prostatic Hyperplasia and Associated Fluctuations with Tamsulosin Administration.
Gotoh M; Matsukawa Y; Funahashi Y; Kato M; Maseki Y; Narita H; Kamihira O; Hattori R
Low Urin Tract Symptoms; 2012 Jan; 4(1):45-50. PubMed ID: 26676459
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and safety of imidafenacin as add-on treatment for persistent overactive bladder symptoms despite α-blocker treatment in patients with BPH: the ADDITION study.
Takeda M; Nishizawa O; Gotoh M; Yoshida M; Takahashi S; Masumori N
Urology; 2013 Oct; 82(4):887-93. PubMed ID: 23953605
[TBL] [Abstract][Full Text] [Related]
10. Effect of naftopidil on nocturia after failure of tamsulosin.
Oh-oka H
Urology; 2008 Nov; 72(5):1051-5. PubMed ID: 18817955
[TBL] [Abstract][Full Text] [Related]
11. Clinical effect of alpha 1D/A adrenoceptor inhibitor naftopidil on benign prostatic hyperplasia: an international prostate symptom score and King's Health Questionnaire assessment.
Awa Y; Suzuki H; Hamano S; Okano T; Sakurayama Y; Ohki T; Egoshi K; Ota S; Mori I; Ichikawa T
Int J Urol; 2008 Aug; 15(8):709-15. PubMed ID: 18662175
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of supplemental administration of Eviprostat in patients with benign prostatic hyperplasia with persistent symptoms following treatment with alpha1-adrenoceptor blocker].
Naruoka T; Suzuki Y; Furuta A; Endo K; Sugaya S; Egawa S
Hinyokika Kiyo; 2008 May; 54(5):341-4. PubMed ID: 18546857
[TBL] [Abstract][Full Text] [Related]
13. [Add-on effect of dutasteride in patients with benign prostatic hyperplasia treated with alpha blocker : its effect on overactive bladder].
Wada N; Hashidume K; Tamaki G; Kita M; Iwata T; Matsumoto S; Kakizaki H
Hinyokika Kiyo; 2012 Sep; 58(9):475-80. PubMed ID: 23070385
[TBL] [Abstract][Full Text] [Related]
14. [The effectiveness of naftopidil in patients with benign prostatic hyperplasia evaluated by QOL index].
Nakatsu H; Naoi M; Sekiyama K; Hamano S; Suzuki N; Tanaka M; Murakami S
Hinyokika Kiyo; 2007 Jan; 53(1):13-8. PubMed ID: 17310763
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness and safety of naftopidil for benign prostatic hyperplasia patients with overactive bladder symptoms].
Ge JP; Gong J; Ma HQ; Wei W; Shang XJ; Zhang ZY; Xu S; Wang D; Gao JP
Zhonghua Nan Ke Xue; 2008 Oct; 14(10):927-30. PubMed ID: 19157107
[TBL] [Abstract][Full Text] [Related]
16. Short-term efficacy and long-term compliance/treatment failure of the alpha1 blocker naftopidil for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Masumori N; Hashimoto J; Itoh N; Tsukamoto T;
Scand J Urol Nephrol; 2007; 41(5):422-9. PubMed ID: 17853040
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of naftopidil for nocturia and consequent sleep disturbance in patients with benign prostatic hyperplasia].
Iwaki H; Narita M; Soga H; Sakano Y; Konishi T; Okada Y
Hinyokika Kiyo; 2010 Apr; 56(4):209-13. PubMed ID: 20448444
[TBL] [Abstract][Full Text] [Related]
18. Nocturia Potentially Influences Maintenance of Sexual Function in Elderly Men with Benign Prostatic Hyperplasia.
Ishizuka O; Matsuyama H; Sakai H; Matsubara A; Nagaoka A; Takahashi S; Takeda M; Ozono S; Shiroki R; Shuin T; Hara I; Kakizaki H; Tsukamoto T; Yamanishi T; Yokoyama O; Kakehi Y; Nishizawa O;
Low Urin Tract Symptoms; 2013 May; 5(2):75-81. PubMed ID: 26663374
[TBL] [Abstract][Full Text] [Related]
19. Ramelteon combined with an α1-blocker decreases nocturia in men with benign prostatic hyperplasia.
Kawahara T; Morita S; Ito H; Terao H; Sakata R; Ishiguro H; Tanaka K; Miyamoto H; Matsuzaki J; Kubota Y; Uemura H
BMC Urol; 2013 Jun; 13():30. PubMed ID: 23758651
[TBL] [Abstract][Full Text] [Related]
20. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
